Zai Lab (ZLAB) Retained Earnings (2016 - 2026)
Zai Lab (ZLAB) posted Retained Earnings of -$2.7 billion for Q1 2026, down 1.94% sequentially from -$2.6 billion in Q4 2025, and down 7.12% YoY from -$2.9 billion in Q1 2025.
Zai Lab (ZLAB) Retained Earnings (2016 - 2026) Analysis & Trends
Zai Lab has reported Retained Earnings for 11 years, with the latest figure at -$2.7 billion in Q1 2026.
- Quarterly Retained Earnings fell 7.12% year-over-year to -$2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 billion (down 7.12% YoY) and the FY2025 annual result came in at -$2.6 billion, down 7.16% from the prior year.
- Retained Earnings slipped to -$2.7 billion in Q1 2026 per ZLAB's latest filing, from -$2.6 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$1.5 billion in Q1 2022 and troughed at -$2.7 billion in Q1 2026.
- A 5-year average of -$2.2 billion and a median of -$2.2 billion in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings plunged 58.53% in 2022, then dropped 7.12% in 2026.
- Over 5 years, Retained Earnings stood at -$1.9 billion in 2022, then declined by 17.98% to -$2.2 billion in 2023, then declined by 11.71% to -$2.5 billion in 2024, then retreated by 7.16% to -$2.6 billion in 2025, then declined by 1.94% to -$2.7 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2.7 billion, -$2.6 billion, and -$2.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | -2.73 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.73 Bn |
| Mar 31, 2026 | -2.68 Bn |
| Dec 31, 2025 | -2.63 Bn |
| Sep 30, 2025 | -2.58 Bn |
| Jun 30, 2025 | -2.54 Bn |
| Mar 31, 2025 | -2.50 Bn |
| Dec 31, 2024 | -2.45 Bn |
| Sep 30, 2024 | -2.37 Bn |
| Jun 30, 2024 | -2.33 Bn |
| Mar 31, 2024 | -2.25 Bn |
| Dec 31, 2023 | -2.20 Bn |
| Sep 30, 2023 | -2.10 Bn |
| Jun 30, 2023 | -2.03 Bn |
| Mar 31, 2023 | -1.91 Bn |
| Dec 31, 2022 | -1.86 Bn |
| Sep 30, 2022 | -1.80 Bn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -1.50 Bn |
| Dec 31, 2021 | -1.42 Bn |
| Sep 30, 2021 | -1.21 Bn |